1. The haemodynamic effects of 100 mg of captopril in renovascular hypertension (n = 1 l), essential hypertension (n = 12) and the anephric state (n = 7) were compared. Brachial artery pressure was measured in all patients, and changes in right atrial pressure, pulmonary artery pressure, pulmonary capillary wedge pressure and cardiac output were followed in renovascular and essential hypertension. Nephrectomized patients were studied before and after fluid withdrawal by ultrafiltration.
Introduction
The orally active angiotensin-converting enzyme inhibitor, captopril (SQ 14 225), has now proved to be an effective antihypertensive agent. The drug is thought to act mainly or at least partly through interference with the conversion of angiotension I into angiotension I1 (Case, Atlas, Laragh, Sealey, Sullivan & McKinstry, 1978;  Atkinson 8c Robertson, 1979) . It might therefore be expected that captopril would be especially effective in hypertensive patients with high levels of circulating renin.
Several reports, however, suggest that captopril is also effective when plasma renin or angiotensin I1 are normal or low (Gavras, Brunner, Turini, Kershaw, Tim, Cuttelod, Gavras, Vukovich 8c Atkinson, Brown, Fraser, Leckie, Lever, Morton & Robertson, 1979b; Brunner, Gavras, Waeber, Kershaw, Turini, Vukovich, McKinstry & Gavras, 1979; Johnston, Millar, McGrath & Matthews, 1979; McGregor, Markandu, Roulston 8c Jones, 1979) . Atkinson et al. (19796) , while demonstrating a close correlation between the fall in plasma angiotensin I1 and the fall in blood pressure after the initial dose of captopril, emphasized that this does not establish cause and effect; factors other than the change in angiotensin I1 might be involved. In an effort to assess the importance of plasma renin as a determinant of the cardiovascular responses to captopril, we have compared the short-term haemodynamic effects of this drug in renovascular hypertension, essential hypertension and the anephric state.
Patients and methods
Eleven patients (mean age 47 k SEM 5 years) with renovascular hypertension, who showed angiographic evidence of unilateral renal artery stenosis, 12 patients (age 50 & 3 years) with essential hypertension, and seven normotensive subjects (38 k 4 years) who had undergone bilateral nephrectomy, agreed to participate in the study.
The pretreatment concentration of active renin in plasma was 100 k 24 p-units/ml (range 2!-290 p-units/ml) in renovascular hypertension, 24 & 4 p-units/ml (range 4-68 p-units/ ml) in essential hypertension and 1.7 & 0.3 p-unitslml (range 0.0-3.4 p-unitslml) in nephrectomized patients. The normal range is 15-35 p-unitslml (Derkx, Wenting, Man in 't Veld, Verhoeven & Schalekamp, 1978) .
The patients with renovascular and essential hypertension had a diet containing 100 mmol of sodium/day, and were on placebo for 3 weeks before captopril was given. Studies were performed in the recumbent patient. A catheter was introduced into the brachial artery for measuring arterial pressure and for blood sampling. A Swan-Ganz flow-directed triplelumen catheter was introduced via an antecubital vein for recording right atrial pressure, pulmonary artery pressure and pulmonary capillary wedge pressure, and for measuring cardiac output by thermodilution. All patients received a 100 mg tablet of captopril.
The nephrectomized subjects underwent dialysis three times a week on a Rhodial-75 single-patient unit with a RP-6 disposable polyacrylonitryl membrane kidney. The recirculating dialysate contained 140 mmol of sodium/l. Captopril (100 mg) or placebo was given in a randomized crossover study on two occasions: (1) after fluid withdrawal by ultrafiltration (weight loss 1.8 2 0.2 kg), 1 h after the patients were disconnected from the kidney, and (2) 2 days after haemodialysis when the patients were fluid-replete. The concentration of active renin in plasma was unresponsive to fluid withdrawal. Blood pressure in these subjects was measured by the London School of Hygiene sphygmomanometer (Rose, Holland & Crowley, 1964) , and mean arterial pressure was calculated according to the formula: mean arterial pressure = diastolic pressure + 0.33 x pulse pressure.
The effects of captopril were maximal after 60-90 min. Data before and 90 min after captopril were analysed by paired t-test statistics. and in the anephric state (Nx). * After ultrafiltration; ** before ultrafiltration. mmHg in the fluid-depleted nephrectomized patients. These changes were significant (P < 0.00 1). Placebo in the fluid-depleted anephric state, and captopril in the fluid-replete anephric state, had no effect on arterial pressure. Heart rate and cardiac index. In all groups of patients heart rate did not change significantly. Cardiac index in renovascular hypertension was 3.5 & 0.1 l/min before captopril and 3.4 & 0.2 l/min after the drug. The difference was not statistically significant. Cardiac index in essential hypertension was 2.9 & 0.1 l/min both before and after captopril.
Results
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Cardiac Jilling pressures and pulmonary artery pressure. Right atrial pressure fell from 2.6 k 0.9 to 1.6 k 0.9 mmHg (P < 0.05) in renovascular hypertension, and from 0.7 rt-0.8 to -0.8 & 0 -9 mmHg ( P < 0.01) in essential hypertension. In Fig. 1 the percentage changes in mean arterial pressure 90 min after captopril as well as the pretreatment plasma levels of active renin are compared in the three groups of patients. It is clear that the effect of captopril on blood pressure was unrelated to pretreatment renin values.
Discussion
In the light of our present knowledge on captopril's mode of action, one would expect its effect on blood pressure to be proportional to the pretreatment level of plasma renin. Such a correlation has indeed been found by some authors (Case et al., 1978; Brunner et al., 1979; Fagard, Amery, Lijnen & Reybrouck, 1979; McGregor et al., 1979) but not by others (Gavras et al., 1978; Bravo et al., 1979; Johnston et al., 1979) . The correlation, if it was found, was rather weak or depended on inclusion of data obtained in patients with high plasma renin on low sodium diet or diuretics. In the present study the antihypertensive effect of captopril was similar in renovascular and essential hypertension despite the marked difference in pretreatment plasma renin.
Our haemodynamic studies confirm that captopril acts as a combined arterial and venous dilator (Cody, Tarazi, Bravo & Fouad, 1978; Tarazi, Fouad, Ceimo & Bravo, 1979; Turini, Brunner, Gribic, Waeber & Gavras, 1979) , which in contrast to other vasodilators, does not lead to reflex tachycardia. Again, the effects of captopril on systemic and pulmonary haemodynamics were not different in our groups with renovascular and essential hypertension despite the difference in renin.
Diuretic treatment is known to enhance captopril's antihypertensive effect (Case et al., 1978; Brunner et al., 1979; Johnston et al., 1979) , and in severe sodium depletion serious hypotensive responses have been observed (Case et al., 1978; Atkinson, Brown, Davies, Fraser, Leckie, Lever, Morton & Robertson, 1979a) . This is often used as an argument in favour of the concept that captopril acts through inhibition of renin-mediated angiotensin I1 formation, because plasma renin is markedly increased by sodium and fluid depletion. It is, however, by no means certain that the increase in renin is the cause of the augmented blood pressure response to captopril. Actually, we found that captopril was capable of lowering blood pressure in anephric subjects only when they were fluid-depleted, whereas plasma renin after fluid depletion was as low as in the fluid-replete state. Blood pressure in the fluid-depleted anephric subjects was lowered by 16% 90 min after captopril, and this is comparable with the effects we observed in renovascular and essential hypertension (Fig. 1) .
These findings suggest that the antihypertensive action of captopril is largely independent of circulating renin.
